Schon Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.25 Cr
as on 10-01-2025
- Paid Up Capital ₹ 1.23 Cr
as on 10-01-2025
- Company Age 30 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 14.96 Cr
as on 10-01-2025
- Satisfied Charges ₹ 20.65 Cr
as on 10-01-2025
- Revenue 27.21%
(FY 2022)
- Profit 12.13%
(FY 2022)
- Ebitda 1.88%
(FY 2022)
- Net Worth 6.94%
(FY 2022)
- Total Assets 6.41%
(FY 2022)
About Schon Pharmaceuticals
The Corporate was formerly known as Schon Pharmaceuticals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.25 Cr and a paid-up capital of Rs 1.23 Cr.
The company currently has active open charges totaling ₹14.96 Cr. The company has closed loans amounting to ₹20.65 Cr, as per Ministry of Corporate Affairs (MCA) records.
Anil Bhatia, Rekha Bhatia, Sunil Bhatia, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24231MP1994PLC007829
- Company No.
007829
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
30 Sep 1994
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Schon Pharmaceuticals Limited offer?
Schon Pharmaceuticals Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup.
Who are the key members and board of directors at Schon Pharmaceuticals?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunil Bhatia  | Director | 30-Sep-1994 | Current |
| Rekha Bhatia | Director | 30-Sep-1994 | Current |
| Prashant Singh | Director | 01-Apr-2014 | Current |
| Anil Bhatia | Director | 30-Sep-1994 | Current |
| Pooja Bhatia | Director | Current |
Financial Performance of Schon Pharmaceuticals.
Schon Pharmaceuticals Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 27.21% increase. The company also saw a substantial improvement in profitability, with a 12.13% increase in profit. The company's net worth moved up by a moderate rise of 6.94%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Schon Pharmaceuticals?
In 2022, Schon Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Sidbi Creation Date: 23 Jan 2024 | ₹3.96 Cr | Open |
Sidbi Creation Date: 11 Jan 2022 | ₹2.00 Cr | Open |
Axis Bank Limited Creation Date: 26 Oct 2018 | ₹9.00 Cr | Open |
How Many Employees Work at Schon Pharmaceuticals?
Schon Pharmaceuticals has a workforce of 73 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Schon Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Schon Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
